Comparative Effectiveness of Different Combinations of Treatment Interventions in Patients with Stroke at the Convalescence Stage Based on the Markov Decision Process
Table 1
General information of patients with stroke at the convalescence stage.
n = 835
Male n = 501
Female n = 334
Age n (%)
18–45 years
51 (6.11)
40 (7.98)
11 (3.29)
46–65 years
251 (30.06)
173 (34.53)
78 (23.35)
≥66 years
533 (63.83)
288 (57.49)
245 (73.35)
Disease history n (%)
None
76 (9.10)
48 (9.58)
28 (8.38)
Have one
262 (31.38)
165 (32.93)
97 (29.04)
Have at least two
497 (59.52)
288 (57.49)
209 (62.57)
Complication n (%)
None
614 (73.53)
372 (74.25)
242 (72.46)
Have at least one
221 (26.47)
129 (25.75)
92 (27.54)
Western medicine diagnosis n (%)
Ischaemic stroke
637 (76.29)
378 (75.45)
259 (77.54)
Haemorrhagic stroke
198 (23.71)
123 (24.55)
75 (22.46)
Syndrome differentiation of TCM n (%)
Wind-fired disturbance type
13 (1.56)
8 (1.60)
5 (1.50)
Phlegm-blocking type
498 (59.64)
315 (62.87)
183 (54.79)
Yin-deficiency type
64 (7.66)
37 (7.39)
27 (8.08)
Qi deficiency and blood stasis type
227 (27.19)
123 (24.55)
104 (31.14)
Phlegm-heat type
33 (3.95)
18 (3.59)
15 (4.49)
Levels of neurological functional impairment n (%)
